Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgical Science Sweden ABSUSRF 84 Forward Rate of Return (Yacktman) % is 11.03% as of Jun. 2026, which is 48% below its 10-year median of 21.09. GuruFocus rates SUSRF with a GF Score™ of 84/100 and a GF Value™ of $19.48 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 340 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks worse than 57.94% on this metric.
Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Surgical Science Sweden AB's forward rate of return for was 11.03%.
The historical rank and industry rank for Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % or its related term are showing as below:
SUSRF'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 8.96 Med: 21.09 Max: 27
Current: 8.96
During the past 11 years, Surgical Science Sweden AB's highest Forward Rate of Return was 27.00. The lowest was 8.96. And the median was 21.09.
SUSRF's Forward Rate of Return (Yacktman) % is ranked worse than 57.94% of 340
companies
in the Healthcare Providers & Services industry
Industry Median: 12.07
vs SUSRF: 8.96
Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Surgical Science Sweden AB (OTCPK:SUSRF) Forward Rate of Return (Yacktman) % Explanation
Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.
Be Aware
In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.
Surgical Science Sweden AB Forward Rate of Return (Yacktman) % Related Terms
Surgical Science Sweden AB Forward Rate of Return (Yacktman) % Historical Data
* Premium members only.
The historical data trend for Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB Forward Rate of Return (Yacktman) % Chart
SUSRF vs VEEV, BTSG, HQY: Forward Rate of Return (Yacktman) % Comparison
For the Health Information Services subindustry, Surgical Science Sweden AB's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB Forward Rate of Return (Yacktman) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % falls into.
Surgical Science Sweden AB Forward Rate of Return (Yacktman) % Calculation
Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Rate of Return (Yacktman) % of 11.03% mean?
Surgical Science Sweden AB (SUSRF) has a Forward Rate of Return (Yacktman) % of 11.03% as of Jun. 2026. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Surgical Science Sweden AB and its competitors. This is 48% below median its historical median of 21.09. Over the past decade, Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % has ranged from 8.96 to 27.00. According to the industry distribution chart, Surgical Science Sweden AB ranks #197 out of 340 companies in the Healthcare Providers & Services industry, placing it in the top 57.9%.
Is Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % too high?
Surgical Science Sweden AB's current Forward Rate of Return (Yacktman) % of 11.03% is 48% below median its 10-year median of 21.09. Over the past 10 years, this metric has ranged from a low of 8.96 to a high of 27.00. The Healthcare Providers & Services industry median Forward Rate of Return (Yacktman) % is 12.07. Surgical Science Sweden AB's value of 11.03% is 8.6% below this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #197 out of 340 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Surgical Science Sweden AB has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Forward Rate of Return (Yacktman) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #197 out of 340 companies for Forward Rate of Return (Yacktman) %. This places Surgical Science Sweden AB in the lower half of its industry. The industry median Forward Rate of Return (Yacktman) % is 12.07. Surgical Science Sweden AB's value of 11.03% is 8.6% below this benchmark. Historically, Surgical Science Sweden AB's own Forward Rate of Return (Yacktman) % has ranged from 8.96 to 27.00 over the past decade. While the company's 10-year median is 21.09 vs. the industry median of 12.07, Surgical Science Sweden AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Rate of Return (Yacktman) % for a Healthcare Providers & Services company?
The median Forward Rate of Return (Yacktman) % among Healthcare Providers & Services companies is 12.07, based on 340 companies in the industry. Companies in the top quartile (top 25%) have a Forward Rate of Return (Yacktman) % significantly above this median, while those in the bottom quartile fall well below. However, Forward Rate of Return (Yacktman) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current Forward Rate of Return (Yacktman) % of 11.03% is 8.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Rate of Return (Yacktman) % mean?
A high Forward Rate of Return (Yacktman) % can signal that a stock is expensive relative to its fundamentals. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median Forward Rate of Return (Yacktman) % is 12.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current Forward Rate of Return (Yacktman) % is 11.03%, which is 48% below median its own 10-year median of 21.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.48, compared to a current price of $5.00 — trading 74.3% below its estimated fair value. The current Forward Rate of Return (Yacktman) % is 11.03%, which is 48% below median its 10-year median of 21.09 and 8.6% below the Healthcare Providers & Services industry median of 12.07. Surgical Science Sweden AB's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Rate of Return (Yacktman) % calculated?
Forward Rate of Return (Yacktman) % is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Forward Rate of Return (Yacktman) % is 11.03% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of $5.00 is trading 74.3% below its estimated GF Value™ of $19.48.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for SUSRF:
Forward Rate of Return (Yacktman) %: 11.03% (48% below median its 10-year median of 21.09)
GF Value™: $19.48 vs. price of $5.00 (74.3% below fair value)
Industry Position: 8.6% below the Healthcare Providers & Services median (#197 of 340)
No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
84GF Score
Get the complete analysis for SUSRF
Forward Rate of Return (Yacktman) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUSRF has been successfully added to your 
